Helga Hagman
knuten till universitetet, Dr Med1 - 6 av 6Sidstorlek: 250
Sortera efter: Utgivningsår
- 2019
-
Cost analysis comparison between peripherally inserted central catheters and implanted chest ports in patients with cancer—A health economic evaluation of the PICCPORT trial
Knut Taxbro, Fredrik Hammarskjöld, David Juhlin, Helga Hagman, Lars Bernfort & Sören Berg, 2019 nov 12, I : Acta Anaesthesiologica Scandinavica.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2018
Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer
Helga Hagman, Pär Ola Bendahl, Jon Lidfeldt, Mattias Belting & Anders Johnsson, 2018 dec, I : PLoS ONE. 13, 12, e0209838.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2017
A targeted approach to maintenance of tumour response. Clinical and translational studies in metastatic colorectal cancer.
Helga Hagman, 2017, Lund: Lund University: Faculty of Medicine. 127 s.Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)
-
Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer
Helga Hagman, Pär-Ola Bendahl, Olle Melander, Jan Sundberg, Anders Johnsson & Mattias Belting, 2017, I : Acta Oncologica. 56, 5, s. 653-660Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2016
-
A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
Helga Hagman, Jan-Erik Frödin, Åke Berglund, Jan Sundberg, Lene Vestermark, Maria Albertsson, Eva Fernebro & Anders Johnsson, 2016 jan, I : Annals of Oncology. 27, 1, s. 140-147Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
- 2013
-
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial.
Anders Johnsson, Helga Hagman, Jan-Erik Frödin, Åke Berglund, N. Keldsen, Eva Fernebro, J Sundberg, R De Pont Christensen, K-L Garm Spindler, D Bergström & A Jakobsen, 2013, I : Annals of Oncology. 24, 9, s. 2335-2341Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift